Metabolic surgery may protect against admission for COVID-19 in persons with nonalcoholic fatty liver disease

BACKGROUND: SARS-CoV-2 (COVID-19) disease causes significant morbidity and mortality through increased inflammation and thrombosis. Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are states of chronic inflammation and indicate advanced metabolic disease. OBJECTIVE:...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Surg Obes Relat Dis
Autors principals: Tignanelli, Christopher J., Bramante, Carolyn T., Dutta, Nirjhar, Tamariz, Leonardo, Usher, Michael G., Ikramuddin, Sayeed
Format: Artigo
Idioma:Inglês
Publicat: Published by Elsevier Inc. on behalf of American Society for Bariatric Surgery. 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238640/
https://ncbi.nlm.nih.gov/pubmed/34326020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.soard.2021.05.029
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars